West receives exhibitor award at interphex 2022 for proprietary deltacube™ modeling platform

The deltacube™ modeling platform is an analytics platform aimed at container closure system (ccs) selection, optimization, and usage exton, pa. , may 24, 2022 /prnewswire/ -- west pharmaceutical services, inc. (nyse: wst), a global leader in innovative solutions for injectable drug administration, today announced it received the biotech innovation award for the deltacube™ modeling platform at the interphex 2022 technical conference in new york city.
WST Ratings Summary
WST Quant Ranking